Evidence map›Paper›PMID 41647509›Full record

ReviewFrontiers in medicine2026

Sarcopenia in type 2 diabetes mellitus: an imaging review.

Lei He, Guanghua Luo, Hongtao Jiang, Li Zhang, Yusheng Li, Wenbin Gu, Qiqun Zeng, Jingjun Zhu, Jincai Liu, Hao Lei and 1 more

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Observational
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Lei HeDepartment of Radiology, The First Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang, Hunan, China.
Guanghua LuoDepartment of Radiology, The First Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang, Hunan, China.
Hongtao JiangDepartment of Radiology, The First Affiliated Hospital, Shaoyang University, Shaoyang, Hunan, China.
Li ZhangDepartment of Radiology, The First Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang, Hunan, China.
Yusheng LiDepartment of Radiology, The First Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang, Hunan, China.
Wenbin GuDepartment of Radiology, The First Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang, Hunan, China.
Qiqun ZengDepartment of Radiology, The First Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang, Hunan, China.
Jingjun ZhuDepartment of Radiology, The First Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang, Hunan, China.
Jincai LiuDepartment of Radiology, The First Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang, Hunan, China.
Hao LeiDepartment of Radiology, The First Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang, Hunan, China.
Heng ZhaoDepartment of Radiology, The First Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang, Hunan, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Sarcopenia is characterized by an age-related decline in muscle mass, strength, or endurance. It is increasingly prevalent in patients with type 2 diabetes mellitus (T2DM) and is now regarded as a key complication of the disease. Additionally, it has a significant impact on patients' prognosis. Imaging methods are crucial tools for assessing muscle mass and microchanges. Moreover, they can facilitate the early diagnosis of sarcopenia. Thus, this article reviews the pathological basis and clinical manifestations of sarcopenia in T2DM, the advantages and disadvantages of imaging assessment methods, their specific applications, imaging manifestations, and research progress.

Indexed as

computed tomographydual-energy x-ray absorptiometrymagnetic resonance imagingsarcopeniatype 2 diabetes mellitusultrasound

Identifiers

PMID41647509
PMCPMC12868266

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.